Oxford Immunotec (OXFD) 12.10 $OXFD Oxford Immunotec

New Post Public Reply Private Reply Replies (0) Message Board

Sep 27, 2016 at 5:06 AM

Oxford Immunotec (OXFD) 12.10 $OXFD

Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation
Globe Newswire - Thu Sep 01, 6:17AM CDT
OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, today announced that the U.S. Magistrate Judge in the Company's patent infringement lawsuit against Qiagen, Inc., Quest Diagnostics, Inc. and Laboratory Corporation of America Holdings has issued a recommendation denying in substantial part the defendants' motion to dismiss the Company's claims. In issuing his recommendation, the magistrate judge stated, "At this early juncture, the Court concludes that the in vitro aspect of the plaintiff's tuberculosis test is an 'inventive concept' because it improves on prior methods of detecting tuberculosis infection." The magistrate judge's recommendation should now allow the Company to press forward with its case against the three defendants, asserting infringement of its six patents relating to methods for diagnosing TB infection.
DGX: 84.61 (-0.83), OXFD: 12.10 (+0.12)

Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference
Globe Newswire - Wed Aug 24, 2:15PM CDT
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that Rick Altieri, Chief Financial Officer, will present at the Baird 2016 Global Healthcare Conference on Wednesday, September 7, 2016, at 2:35 p.m. ET at the New York Palace in New York, NY.
OXFD: 12.10 (+0.12)

Oxford Immunotec Reports Second Quarter 2016 Financial Results
Globe Newswire - Tue Aug 02, 6:00AM CDT
- Second quarter revenue of $19.2 million, increased 34% compared to prior year period
OXFD: 12.10 (+0.12)

Oxford Immunotec Enters into Definitive Agreement to Acquire Imugen
Globe Newswire - Thu Jun 23, 3:05PM CDT
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 23, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced it has entered into a definitive agreement to acquire substantially all of the assets of Imugen, Inc., a Massachusetts-based clinical laboratory focused on developing and performing specialized testing for tick-borne diseases, for $22.2 million in an all cash transaction expected to close on July 1, 2016.
OXFD: 12.10 (+0.12)

Oxford Immunotec to Present at the Jefferies 2016 Healthcare Conference
Globe Newswire - Fri May 20, 10:45AM CDT
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 20, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will present at the Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016, at 2:00 p.m. ET at the Grand Hyatt in New York, NY.
OXFD: 12.10 (+0.12)

Oxford Immunotec reports 1Q loss
Automated Insights - Tue May 03, 7:54AM CDT
ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Tuesday reported a loss of $7 million in its first quarter.
OXFD: 12.10 (+0.12)

Oxford Immunotec Reports First Quarter 2016 Financial Results
Globe Newswire - Tue May 03, 6:00AM CDT
- First quarter revenue of $17.1 million, increased 24% compared to prior year period
OXFD: 12.10 (+0.12)

Oxford Immunotec Schedules First Quarter 2016 Earnings Release and Conference Call for May 3, 2016
Globe Newswire - Wed Apr 20, 10:08AM CDT
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 20, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that it plans to release first quarter 2016 financial results prior to market open on Tuesday, May 3, 2016. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.
OXFD: 12.10 (+0.12)

Oxford Immunotec Global appoints Patrick J. Balthrop, Sr. to board
M2 - Tue Feb 02, 3:04AM CST
Diagnostics company Oxford Immunotec Global (NasdaqGM:OXFD) revealed on Monday the election of Patrick J. Balthrop, Sr. to its board of directors.
OXFD: 12.10 (+0.12), LMNX: 22.57 (-0.22)

Patrick J. Balthrop, Sr., Former CEO of Luminex, Joins Oxford Immunotec Board of Directors
Globe Newswire - Mon Feb 01, 4:00PM CST
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced the appointment of Patrick J. Balthrop, Sr. to its Board of Directors.
OXFD: 12.10 (+0.12), LMNX: 22.57 (-0.22)

Oxford Immunotec to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
Thomson Reuters ONE - Tue Jan 26, 11:06AM CST
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016, at 1:25 p.m. EST at the Waldorf Astoria in New York, NY.
OXFD: 12.10 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China, Europe, Africa Team Up for Green Energy Push

The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...

Deadline Looms for BETR Investors: Take Action Now

What’s the Fuss About? Alright folks, let’s lay this out simple: Better Home & Finance Holding Company (NASDAQ: BETR) is in hot water. A class action’s been slapped on them, accusing the firm of sugarcoating its business prospects. If you bought BETR shares between March 13, 2026, and May 7, 2026, you might have a dog in this fight. Buckle up, because the stakes are...

NSAP's First Board Aims to Revolutionize Autism Care

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

UTulsa's New Scholarship Fund: A Bold Step Forward

Pioneering Education at UTulsa Have you ever heard of a private university in the middle of America's heartland capping its undergraduate tuition? That's exactly what the University of Tulsa is doing, setting its tuition and fees at $25,000 a year come fall 2027. And they're not stopping there. With a robust $4 million boost from the Asbjornson Foundation, they're rolling...

QVC Group Readies 2026 Q3 Results, Faces Retail Shift

The Changing Faces of QVC Group Something tells me that the retail landscape’s a different beast in 2026. QVC Group, Inc. (NASDAQ:QVCG) has wired up for a crucial update we’ve all been waiting for—announcing their third quarter fiscal 2026 results. Mark your calendars for November 16th, because that’s when the SEC will get their hands on the 10-Q, and we’ll get...

QuidelOrtho Shares Plunge 14% Amid Legal Scrutiny

QuidelOrtho's Rocky Road Oh, it's been a roller coaster for QuidelOrtho's stock. Lately, it’s like holding onto a greased pole in a thunderstorm. November 9th, 2026, wasn't a friend to QDEL shareholders; the stock's down about 14%, and now some legal eagles want to know if there's more to the story. When you go poking around in the financials and spotlight that nasty...

Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Trimble's New Machine Control Tech Promises Big Gains

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...

Millrose Faces Class Action Over Misleading Investors

Millrose Properties Steps Into Legal Hot Water Ah, stocks and legal squabbles—a pairing as old as Wall Street itself. Now, folks, it seems Millrose Properties, Inc. has stepped right onto the chopping block with a lawsuit knocking on their door over claims they misled investors. The suits from the DJS Law Group aren't mince words: we're talking alleged violations of the...

Lauri Thompson Joins UWSN Board: A New Era Begins

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....